Fund shareholders of Castle Biosciences Inc
ISIN US14843C1053 · United States · LEI 2549007M2Q4HLR1XD252
- Fund shareholders
- 233
- Of which ETFs
- 60 173 other funds
- Value held
- 253.2M $
- Share of capital
- 32.6 % of 30.5M shares on Jul 23, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 659 | 19.5K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 658 | 16.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Putnam VT Global Asset Allocation Fund Putnam Variable Trust | 652 | 16K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 627 | 15.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 568 | 13.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 473 | 11.6K $ | 0.07 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 468 | 11.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust | 431 | 10.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TEXAS CAPITAL TEXAS EQUITY INDEX ETF Texas Capital Funds Trust | 413 | 10.1K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Equity Fund American Century ETF Trust | 388 | 11.5K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Spectrum Fund Meeder Funds | 387 | 9.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 373 | 9.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| WisdomTree U.S. SmallCap Quality Growth Fund WisdomTree Trust | 324 | 8K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 323 | 7.9K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Common Stock Index Portfolio EQ Advisors Trust | 200 | 4.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Responsible U.S. Equity ETF American Century ETF Trust | 190 | 5.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Enhanced U.S. All-Cap Equity ETF Fidelity Covington Trust | 185 | 4.5K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 171 | 4.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 171 | 4.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 145 | 3.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 142 | 3.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 96 | 2.4K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Texas Equity ETF iShares Trust | 74 | 1.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 73 | 1.8K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 65 | 1.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 52 | 1.3K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 43 | 1.1K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 39 | 957.5 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 29 | 857.5 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 21 | 621 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Longview Advantage ETF RBB Fund Trust | 11 | 325.3 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 8 | 236.6 $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 7 | 171.9 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Advisors Capital Small/Mid Cap Fund NEIMAN FUNDS | 2.89 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Health Care Services ETF SPDR SERIES TRUST | 1.90 % | as of Mar 31, 2026 ↗ |
| Buffalo Small Cap Growth Fund Buffalo Funds | 1.51 % | as of Mar 31, 2026 ↗ |
| Wasatch Micro Cap Fund WASATCH FUNDS TRUST | 1.21 % | as of Mar 31, 2026 ↗ |
| Wasatch Ultra Growth Fund WASATCH FUNDS TRUST | 1.05 % | as of Mar 31, 2026 ↗ |
| Buffalo Early Stage Growth Fund Buffalo Funds | 0.99 % | as of Mar 31, 2026 ↗ |
| Nuveen Small Cap Value Opportunities Fund Nuveen Investment Trust | 0.98 % | as of Mar 31, 2026 ↗ |
| SmallCap Account Principal Variable Contract Funds, Inc | 0.92 % | as of Mar 31, 2026 ↗ |
| SmallCap Fund Principal Funds, Inc | 0.83 % | as of Apr 30, 2026 ↗ |
| Disciplined U.S. Small Cap Equity Portfolio GLENMEDE FUND INC | 0.77 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 233 | +16 | 9,954,924 | +0.2 % |
| 2026Q1 | 217 | +5 | 9,938,414 | -6.5 % |
| 2025Q4 | 212 | +6 | 10,631,132 | -4.9 % |
| 2025Q3 | 206 | -16 | 11,182,594 | +9.3 % |
| 2025Q2 | 222 | +3 | 10,231,604 | +5.4 % |
| 2025Q1 | 219 | -4 | 9,704,095 | -2.9 % |
| 2024Q4 | 223 | +15 | 9,998,433 | +3.5 % |
| 2024Q3 | 208 | +14 | 9,656,269 | +1.4 % |
| 2024Q2 | 194 | +3 | 9,525,099 | +0.1 % |
| 2024Q1 | 191 | +4 | 9,517,639 | -1.4 % |
| 2023Q4 | 187 | 9,656,081 |
Institutional managers
178 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 2,982,946 | 73.2M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 2,758,335 | 67.7M $ | as of Mar 31, 2026 |
| PRINCIPAL FINANCIAL GROUP INC | 1,769,877 | 43.5M $ | as of Mar 31, 2026 |
| Portolan Capital Management, LLC | 1,350,283 | 33.1M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,039,761 | 25.5M $ | as of Mar 31, 2026 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 940,685 | 23.1M $ | as of Mar 31, 2026 |
| Allianz Asset Management GmbH | 811,324 | 19.9M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 769,079 | 18.9M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 728,100 | 17.9M $ | as of Mar 31, 2026 |
| AIGH Capital Management LLC | 590,601 | 14.5M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 559,583 | 13.7M $ | as of Mar 31, 2026 |
| PALISADE CAPITAL MANAGEMENT, LP | 535,884 | 13.2M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 532,800 | 13.1M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 522,127 | 12.8M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 484,441 | 11.9K $ | as of Mar 31, 2026 |
| WASATCH ADVISORS LP | 455,036 | 11.2M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 428,934 | 10.5M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 386,425 | 9.5M $ | as of Mar 31, 2026 |
| Connor, Clark & Lunn Investment Management Ltd. | 377,082 | 9.3M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 353,319 | 8.7M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 341,171 | 8.4M $ | as of Mar 31, 2026 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 298,941 | 7M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 273,101 | 6.7M $ | as of Mar 31, 2026 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 268,535 | 6.6M $ | as of Mar 31, 2026 |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 264,396 | 6.5M $ | as of Mar 31, 2026 |
Declared shareholders of Castle Biosciences Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| RTW Investments, LP and 1 other | 9.30 % | 2,758,335 | as of Mar 31, 2026 · SCHEDULE 13G |
| Portolan Capital Management, LLC and 1 other | 4.45 % | 1,350,283 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Castle Biosciences Inc". https://titelia.com/en/stocks/castle-biosciences-inc-US14843C1053